Skip to main content

Advertisement

Log in

Identification of Potential Markers Related to Neoadjuvant Chemotherapy Sensitivity of Breast Cancer by SELDI-TOF MS

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Neoadjuvant chemotherapy (NACT) is known to be beneficial for patients with locally advanced breast cancer. However, there is still no unified standard on the evaluation of NACT. To identify the potential markers related to NACT sensitivity of breast cancer, in the present study, we examined the protein spectrum of breast cancer tissues before and after NACT using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). Totally, 87 protein samples were extracted from tissues of breast cancer, with 30 from patients before NACT, 30 from patients after NACT, and 27 from patients without any treatment. To eliminate confounding factors a couple of tissue samples from the same patient were mixed. SELDI-TOF MS analysis demonstrated that the intensities of eight different protein peaks, i.e., 26,055.46, 17,898.94, 8,949.50, 11,652.02, 11,053.48, 38,546.56, 5,825.89, and 22,250.63 Da, were higher in samples after NACT than those before NACT. Although further experiments are needed to prove the reliability of the proteins identified in this study, our results will help the establishment of protein model based on drug resistance-related protein peaks to screen whether a patient is suitable for adopting NACT and to improve cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Akhsan, A., & Aryandono, T. (2010). Asian Pacific Journal of Cancer Prevention, 11, 759–761.

    Google Scholar 

  2. Khokher, S., Mahmood, S., & Khan, S. A. (2010). Asian Pacific Journal of Cancer Prevention, 11, 303–308.

    Google Scholar 

  3. Garces, C. A., & Cance, W. G. (2004). The American Surgeon, 70, 565–569.

    Google Scholar 

  4. Choi, J. H., Lim, H. I., Lee, S. K., Kim, W. W., Kim, S. M., Cho, E., et al. (2010). Journal of Surgical Oncology, 102, 392–397.

    Article  Google Scholar 

  5. Straver, M. E., Aukema, T. S., Olmos, R. A., Rutgers, E. J., Gilhuijs, K. G., Schot, M. E., et al. (2010). European Journal of Nuclear Medicine and Molecular Imaging, 37, 1069–1076.

    Article  Google Scholar 

  6. Keune, J. D., Jeffe, D. B., Schootman, M., Hoffman, A., Gillanders, W. E., & Aft, R. L. (2010). American Journal of Surgery, 199, 477–484.

    Article  Google Scholar 

  7. Masuda, H., Masuda, N., Kodama, Y., Ogawa, M., Karita, M., Yamamura, J., et al. (2011). Cancer Chemotherapy and Pharmacology, 67, 911–917.

    Article  CAS  Google Scholar 

  8. Tewari, M., Pradhan, S., Singh, U., Singh, T. B., & Shukla, H. S. (2010). Asian Journal of Surgery, 33, 157–167.

    Article  Google Scholar 

  9. Ricolleau, G., Charbonnel, C., Lode, L., Loussouarn, D., Joalland, M. P., Bogumil, R., et al. (2006). Proteomics, 6, 1963–1975.

    Article  CAS  Google Scholar 

  10. Ushijima, M., Miyata, S., Eguchi, S., Kawakita, M., Yoshimoto, M., Iwase, T., et al. (2007). Cancer Information, 3, 285–293.

    Google Scholar 

  11. Gast, M. C., van Dulken, E. J., van Loenen, T. K., Kingma-Vegter, F., Westerga, J., Flohil, C. C., et al. (2009). The International Journal of Biological Markers, 24, 130–141.

    CAS  Google Scholar 

  12. Gast, M. C., Van Gils, C. H., Wessels, L. F., Harris, N., Bonfrer, J. M., Rutgers, E. J., et al. (2009). Oncology Reports, 22, 205–213.

    Article  CAS  Google Scholar 

  13. Gast, M. C., van Gils, C. H., Wessels, L. F., Harris, N., Bonfrer, J. M., Rutgers, E. J., et al. (2009). Clinical Chemistry and Laboratory Medicine, 47, 694–705.

    Article  CAS  Google Scholar 

  14. Gast, M. C., Schellens, J. H., & Beijnen, J. H. (2009). Breast Cancer Research and Treatment, 116, 17–29.

    Article  CAS  Google Scholar 

  15. Gast, M. C., Engwegen, J. Y., Schellens, J. H., & Beijnen, J. H. (2008). BMC Medical Genomics, 1, 4.

    Article  Google Scholar 

  16. Lu, H. B., Zhou, J. H., Ma, Y. Y., Lu, H. L., Tang, Y. L., Zhang, Q. Y., et al. (2010). Japanese Journal of Clinical Oncology, 40, 336–342.

    Article  Google Scholar 

  17. Fan, Y., Wang, J., Yang, Y., Liu, Q., Yu, J., Zheng, S., et al. (2010). Journal of Cancer Research and Clinical Oncology, 136, 1243–1254.

    Article  CAS  Google Scholar 

  18. Solassol, J., Rouanet, P., Lamy, P. J., Allal, C., Favre, G., Maudelonde, T., et al. (2010). Oncogene, 29, 550–560.

    Article  CAS  Google Scholar 

  19. Wang, X., Dai, S., Zhang, Z., Liu, L., Wang, J., Xiao, X., et al. (2009). European Journal of Cancer Care, 18, 625–635.

    Article  CAS  Google Scholar 

  20. Apweiler, R., Martin, M. J., O’Donovan, C., Magrane, M., Alam-Faruque, Y., Antunes, R., et al. (2010). Nucleic Acids Research, 38, D142–D148.

    Article  CAS  Google Scholar 

  21. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., & Chan, D. W. (2002). Clinical Chemistry, 48, 1296–1304.

    CAS  Google Scholar 

  22. Li, J., Orlandi, R., White, C. N., Rosenzweig, J., Zhao, J., Seregni, E., et al. (2005). Clinical Chemistry, 51, 2229–2235.

    Article  CAS  Google Scholar 

  23. Pusztai, L., Gregory, B. W., Baggerly, K. A., Peng, B., Koomen, J., Kuerer, H. M., et al. (2004). Cancer, 100, 1814–1822.

    Article  CAS  Google Scholar 

  24. Pietrowska, M., Polanska, J., Marczak, L., Behrendt, K., Nowicka, E., Stobiecki, M., et al. (2010). Journal of Translational Medicine, 8, 66.

    Article  Google Scholar 

  25. van Winden, A. W., Gast, M. C., Beijnen, J. H., Rutgers, E. J., Grobbee, D. E., Peeters, P. H., et al. (2009). BMC Medical Genomics, 2, 4.

    Article  Google Scholar 

  26. Li, Y., Wen, Z., Xiao, J., Yin, H., Yu, L., Yang, L., et al. (2011). BMC Bioinformatics, 12, 14.

    Article  Google Scholar 

  27. Deng, X., Geng, H., Bastola, D. R., & Ali, H. H. (2006). Computational Biology and Chemistry, 30, 425–433.

    Article  CAS  Google Scholar 

  28. Chen, W. C., Lai, C. C., Tsai, Y., Lin, W. Y., & Tsai, F. J. (2008). Journal of Clinical Laboratory Analysis, 22, 77–85.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by Provincial Natural Science Foundation of Shandong Province, China (No.Y2008C15).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rongzhan Fu.

Additional information

Zhang and Yuan contribute equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, K., Yuan, K., Wu, H. et al. Identification of Potential Markers Related to Neoadjuvant Chemotherapy Sensitivity of Breast Cancer by SELDI-TOF MS. Appl Biochem Biotechnol 166, 753–763 (2012). https://doi.org/10.1007/s12010-011-9464-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-011-9464-z

Keywords

Navigation